Seattle’s Nohla closes $45M to bring novel stem cell treatment for leukemia to late-stage trials – Endpoints News
Endpoints News |
Seattle's Nohla closes $45M to bring novel stem cell treatment for leukemia to late-stage trials
Endpoints News Seattle's Nohla Therapeutics, a biotech startup spun out of the Fred Hutchinson Cancer Research Center, has raised $45 million in new money to push forward its Phase II cell therapy for cord blood transplants. The new Series B, backed in part by … |
